✦ LIBER ✦

Dendritic cell–tumor cell hybrid vaccination for metastatic cancer

✍ Scribed by Jose Alexandre M. Barbuto; Luis F. C. Ensina; Andreia R. Neves; Patrícia C. Bergami-Santos; Katia R. M. Leite; Ricardo Marques; Frederico Costa; Siderleny C. Martins; Luiz H. Camara-Lopes; Antonio C. Buzaid

Publisher: Springer-Verlag
Year: 2004
Tongue: English
Weight: 285 KB
Volume: 53
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-004-0551-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dendritic/tumor fusion cell-based vaccin

Dendritic/tumor fusion cell-based vaccination against cancer

✍ Shigeo Koido; Eiichi Hara; Sadamu Homma; Kiyotaka Fujise; Jianlin Gong; Hisao Ta 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 103 KB

An autologous dendritic cell canine mamm

An autologous dendritic cell canine mammary tumor hybrid-cell fusion vaccine

✍ R. Curtis Bird; Patricia DeInnocentes; Allison E. Church Bird; Frederik W. van G 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 605 KB

Generation of dendritic cell–tumor cell

Generation of dendritic cell–tumor cell hybrids by electrofusion for clinical vaccine application

✍ Katrina T. Trevor; Cathleen Cover; Yvette W. Ruiz; Emmanuel T. Akporiaye; Evan M 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 567 KB

Whole-cell cancer vaccination: from auto

Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines

✍ Tanja D. de Gruijl; Alfons J. M. van den Eertwegh; Herbert M. Pinedo; Rik J. Sch 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 311 KB

Dendritic-cell-based therapeutic vaccina

Dendritic-cell-based therapeutic vaccination against cancer

✍ Frank O Nestle; Arpad Farkas; Curdin Conrad 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Early clinical trials, in which over 1000 cancer patients received dendritic cell (DC) vaccines, tested different vaccine preparations, but they did not always induce sufficient acquired immunity or meet the expected level of tumor regressions. Current studies aim to improve the DC vaccine approach

Hybrid cell vaccination for cancer immun

Hybrid cell vaccination for cancer immune therapy: First clinical trial with metastatic melanoma

✍ Uwe Trefzer; Guido Weingart; Yingwen Chen; Gunda Herberth; Karin Adrian; Helmut 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 364 KB 👁 2 views

Hybrid cell vaccination is a new cancer immune therapy approach that aims at recruiting T cell help for the induction of tumour specific cytolytic immunity. The vaccines are generated by fusion of the patients' tumour cells with allogeneic MHC class II bearing cells to combine the tumour's antigenic